Goldman Sachs (NYSE: GS) is slated to report fourth quarter 2019 earnings on Wednesday, January 15, before the market opens. Analysts expect earnings to decline to $5.49 per share from $6.04 per share in the prior-year period. Revenues are projected to increase 5% to $8.5 billion.
The biggest change to look forward to in the upcoming results announcement is the revamping of the company’s segments which was announced last Monday. Goldman made these changes in order to improve transparency and accountability.
The results will be reported in four new segments which are Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. The Investing and Lending division, which was said to cause earnings volatility, will cease to exist and its units will be distributed across the new segments.
Although low interest rates are likely to affect margins, higher trading revenue could be an advantage in the fourth quarter. The company has seen weakness across several of its businesses over the past quarters.
Also read: Goldman Sachs Q3 2019 Conference Call Transcript
On Thursday, Goldman Sachs’ stock reached a 52-week high of $243.40 after Bank of America and Buckingham upgraded the stock to Buy. Bank of America’s Michael Carrier cited benefits from a favorable macroeconomic environment and the strategic repositioning as reasons for the upgrade.
The company’s stock has gained 37% over the past one year and 18% over the past three months. It has an average price target of $263.63.
In the third quarter of 2019, Goldman beat revenue estimates but missed earnings expectations. Revenues fell 6% to $8.32 billion, hurt by lower revenue in Investment Banking and Investing & Lending. Earnings fell 24% to $4.79.
A slew of banking companies, including J.P. Morgan (NYSE: JPM), Citigroup (NYSE: C) and Wells Fargo (NYSE: WFC) are set to report earnings this week.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
